NHS Mid and South Essex Integrated Care Board (MSE ICB) has commissioned five new specialist providers to provide ADHD assessments and treatment for adults. This means patients now have more choice for their care provider.
These new service providers provide much-needed additional capacity that will help to meet local demand for adult ADHD services and reduce waiting times for diagnosis and treatment.
The providers listed below have undergone rigorous due diligence and quality assurance processes to ensure they meet the ICB’s standards for safety, clinical effectiveness, and continuity of care. They are an MSE ICB approved route for adult patients requesting referrals for ADHD services.
More options for patients
The following providers now form a network of locally commissioned NHS services for adults in mid and south Essex. In addition to the adult ADHD service already commissioned from Essex University Partnership Trust (EPUT), local GPs can now refer patients directly to one of these providers to support patient choice.
- Atrom Mindcare
- Care ADHD
- Elixir Medics
- Harrow Health
- The Owl Centre
These new providers have been contracted to deliver the same service offer as EPUT. This includes ADHD assessment, diagnosis, and NHS-prescribed medication if clinically necessary.
Patients’ Right to Choose
Patients have the right to choose who provides their ADHD care.
The above providers are commissioned by MSE ICB to support patient choice for mid and south Essex residents. Adult patients can now request a referral to one of these locally commissioned services.
MSE ICB encourages patients to select providers that are accredited and commissioned within the local care system. While patients’ right to choose remains protected, choosing a provider that is part of the locally approved network ensures patient care is safe, coordinated, and aligned with local NHS pathways.
For more information, please visit
New Adult ADHD service providers ADHD prescribing in mid and south Essex About Patient Choice / Right to Choose Patient Choice Policy